IGDB.NSCLC Gene View
Gene Information Microarray Gene Expression Result Treatment Result Microarray Sample Data Cancer Gene Index
 
Gene Information        (help)
Not Matched Gene !
Gene QDPR Ensembl   Chromosome Start End  
Description  
 

< Top >
Microarray Gene Expression Fold Change Result        (help)
( red: up-regulation / green : down-regulation when p value < 0.01)
( gray background : these probesets might have mapping problems. ref 1, ref 2)
Chip Type Probeset Adenocarcinoma Squamous Cell Carcinoma
Fold Change p value q value Fold Change p value q value
 HG_U95  260_at  -0.27  2.84e-4  1.04e-3  -0.35  1.36e-4  5.25e-4
 HG_U133A  209123_at  -0.73  2.16e-18  1.51e-17  -0.52  1.15e-3  1.28e-3
 HG_U133_Plus2  1556205_at  -0.88  9.84e-10  6.87e-9  -0.86  3.37e-8  1.19e-7
 HG_U133_Plus2  1560787_at  -0.17  3.77e-1  4.67e-1  -0.26  2.49e-1  3.05e-1
 HG_U133_Plus2  209123_at  -0.62  3.87e-13  4.20e-12  -0.85  3.26e-20  4.61e-19
 HG_U133_Plus2  238616_at  -0.18  1.62e-1  2.31e-1  -0.32  1.89e-2  2.93e-2
 HG_U133_Plus2  239857_at  -0.85  4.06e-11  3.39e-10  -0.83  2.10e-12  1.23e-11
 Stanford  6088  -0.50  4.51e-2  1.45e-1  -0.60  2.81e-2  1.16e-1
 Agilent_HS_21.6K  9617  -0.22  3.40e-4  3.22e-3  -0.29  2.26e-6  3.13e-5
 Agilent_HS_21.6K  14799  -0.21  1.70e-4  1.85e-3  -0.28  2.85e-6  3.81e-5

< Top >
Adjuvant Cisplatin/vinorelbine Treatment vs Observation Result        (help) (Pubmed)
( red: up-regulation / green : down-regulation when p value < 0.01)
( gray background color : the mapping problems of probeset. ref_1, ref_2)
Chip Type Probeset Adenocarcinoma Squamous Cell Carcinoma
Fold Change p value q value Fold Change p value q value
 HG_U133A  209123_at  0.02  9.25e-1  9.95e-1  -0.16  3.68e-1  1.00e+0

< Top >
Microarray Sample Data        (help)
( The log2 value of tumor samples )
(Average : Average log2 value from Normal Samples.)
        HG_U95 - 260_at    (back)       Save as a PNG file. Save as a PDF file. Save as a PS file.
Gene expression figure

        HG_U133A - 209123_at    (back)       Save as a PNG file. Save as a PDF file. Save as a PS file.
Gene expression figure

        HG_U133_Plus2 - 1556205_at    (back)       Save as a PNG file. Save as a PDF file. Save as a PS file.
Gene expression figure

        HG_U133_Plus2 - 1560787_at    (back)       Save as a PNG file. Save as a PDF file. Save as a PS file.
Gene expression figure

        HG_U133_Plus2 - 209123_at    (back)       Save as a PNG file. Save as a PDF file. Save as a PS file.
Gene expression figure

        HG_U133_Plus2 - 238616_at    (back)       Save as a PNG file. Save as a PDF file. Save as a PS file.
Gene expression figure

        HG_U133_Plus2 - 239857_at    (back)       Save as a PNG file. Save as a PDF file. Save as a PS file.
Gene expression figure

        Stanford - 6088    (back)       Save as a PNG file. Save as a PDF file. Save as a PS file.
Gene expression figure

        Agilent_HS_21.6K - 9617    (back)       Save as a PNG file. Save as a PDF file. Save as a PS file.
Gene expression figure

        Agilent_HS_21.6K - 14799    (back)       Save as a PNG file. Save as a PDF file. Save as a PS file.
Gene expression figure

< Top >
Cancer Gene Index        (help)

If 0 entry was found, please remove the search key "lung cancer".
Keyword DiseaseData Statement PubMed Organism
dihydropteridine reductase leukemias Dihydropteridine reductase activity and neopterin levels in leukemias and lymphomas: is there any correlation between these two parameters? 10706461 Human
dihydropteridine reductase lymphomas Dihydropteridine reductase activity and neopterin levels in leukemias and lymphomas: is there any correlation between these two parameters? 10706461 Human
dihydropteridine reductase leukemias Urinary neopterin levels, blood dihydropteridine reductase activity as well as other frequently used clinical parameters were evaluated in 110 patients suffering from various types of lymphomas and leukemias. 10706461 Human
dihydropteridine reductase lymphomas Urinary neopterin levels, blood dihydropteridine reductase activity as well as other frequently used clinical parameters were evaluated in 110 patients suffering from various types of lymphomas and leukemias. 10706461 Human
dhpr haematological malignancies Our data also suggest that reductions in DHPR activities may also be an underlying cause for the neurological disorders that are commonly seen in patients with haematological malignancies. 10706461 Human
dihydropteridine reductase mastocytoma NADH-specific dihydropteridine reductase in mastocytoma P-815 cells. 6434226 Human
dihydropteridine reductase mastocytoma NADH-specific dihydropteridine reductase [EC 1.6.99.7] was purified from mouse mastocytoma P-815 cells. 6434226 Human
dihydropteridine reductase neoplasms The undifferentiated enzymic composition of neoplasms is reflected by the lower dihydropteridine reductase content of pulmonary tumors than of nonneoplastic human lung. 710385 Human
dihydropteridine reductase tumors The undifferentiated enzymic composition of neoplasms is reflected by the lower dihydropteridine reductase content of pulmonary tumors than of nonneoplastic human lung. 710385 Human
dihydropteridine reductase neuroblastoma Neuroblastoma in a patient with dihydropteridine reductase deficiency. 2209664 Human
dihydropteridine reductase acute lymphoblastic leukemia Hyperphenylalaninemia caused by dihydropteridine reductase deficiency in children receiving chemotherapy for acute lymphoblastic leukemia. 2795366 Human
dihydropteridine reductase neurofibromatosis Other conditions associated with calcification were Sturge-Weber syndrome, neurofibromatosis, Cockayne's syndrome, hypoparathyroidism, arteriovenous malformations, vein of Galen aneurysm, encephalomalacia, cerebral infarcts, subdural hematoma, cerebr 8016912 Human
dihydropteridine reductase arteriovenous malformations Other conditions associated with calcification were Sturge-Weber syndrome, neurofibromatosis, Cockayne's syndrome, hypoparathyroidism, arteriovenous malformations, vein of Galen aneurysm, encephalomalacia, cerebral infarcts, subdural hematoma, cerebr 8016912 Human
dihydropteridine-reductase breast cancer Dihydropteridine-reductase activity in breast cancer. 6266525 Human
dihydropteridine-reductase breast cancers Preliminary report. The dihydropteridine-reductase activity was measured in 206 breast cancers. 6266525 Human

< Top >
Download all image files.
Save all PNG files.    Save all PDF files.    Save all PS files.